Land: Taiwan
Sprache: Chinesisch
Quelle: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
PERTUSSIS TOXOID;;FILAMENTOUS HAEMAGGLUTININ;;AGGLUTINOGENS FIMBRIAE 2+3;;PERTACTIN;;DIPHTHERIA TOXOID;;TETANUS TOXOID;;POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B;;CONJUGATED TO THE TETANUS PROTEIN;;INACTIVATED POLIOVIRUS VACCINE TYPE I;;INACTIVATED POLIOVIRUS VACCINE TYPE II;;INACTIVATED POLIOVIRUS VACCINE TYPE III
賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356)
J07CA06
注射劑
主成分 () ; PERTUSSIS TOXOID (8004001620) ug; DIPHTHERIA TOXOID (8008000100) LF(UNITS); TETANUS TOXOID (8008000200) LF(UNITS); CONJUGATED TO THE TETANUS PROTEIN (8008000230) 18-30ug; INACTIVATED POLIOVIRUS VACCINE TYPE I (8012002201) DU; INACTIVATED POLIOVIRUS VACCINE TYPE II (8012002202) DU; INACTIVATED POLIOVIRUS VACCINE TYPE III (8012002203) DU; POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B (8012020000) ug; FILAMENTOUS HAEMAGGLUTININ (9200050300) ug; AGGLUTINOGENS FIMBRIAE 2+3 (9200090400) ug; PERTACTIN (9900066600) ug
盒裝;;注射針筒;;瓶裝;;盒裝
菌 疫
須由醫師處方使用
SANOFI PASTEUR 1541, AV. MARCEL-MERIEUX, 69280 MARCY L'ETOILE FRANCE FR
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
可使出生後二個月至七歲的孩童對白喉、破傷風、百日咳、小兒麻痺症及侵襲性b型流行性感冒嗜血桿菌感染症產生免疫力。
註銷日期: 2020/01/31; 註銷理由: 自請註銷; 有效日期: 2021/01/19; 英文品名: PediacelTM
已註銷
2006-01-19